SPECIAL EMPHASIS PANELS


To view other meetings from ZAI1 choose calendar year:

Study Section Panel Name Meeting Rosters
ZAI1 CAB-D(M1) NIH SUPPORT FOR CONFERENCES AND SCIENTIFIC MEETINGS (PARENT R13 CLINICAL TRIAL NOT ALLOWED) 03/26/24
ZAI1 TCB-I(M2) NIAID CLINICAL TRIAL PLANNING GRANTS (R34 CLINICAL TRIAL NOT ALLOWED) 03/21/24
ZAI1 RCU-A(M1) ANALYZING EARLY EVENTS IN TB AND TB/HIV INFECTION FOR INTERVENTIONAL TARGETS (R01 CLINICAL TRIAL NOT ALLOWED) 03/21/24
ZAI1 SPJ-D(M1) SUPPORT FOR RESEARCH EXCELLENCE – FIRST INDEPENDENT RESEARCH (SURE-FIRST) AWARD (R16 - CLINICAL TRIAL NOT ALLOWED) 03/21/24
ZAI1 LG-M(M1) FUNDAMENTAL RESEARCH TO UNDERSTAND THE MECHANISMS OF NEUROTROPIC VIRUS-MEDIATED DISEASE (R01 CLINICAL TRIAL NOT ALLOWED) 03/20/24
ZAI1 PP-A(C2) VIROLOGY CORE LABORATORY (VCL) 03/20/24
ZAI1 JTS-I(M1) ALLERGY, IMMUNOLOGY, AND TRANSPLANTATION RESEARCH COMMITTEE (AITC) SPECIAL EMPHASIS PANEL 03/18/24
ZAI1 TCB-I(M1) NIAID CLINICAL TRIAL PLANNING GRANTS (R34 CLINICAL TRIAL NOT ALLOWED) AND INVESTIGATOR INITIATED EXTENDED CLINICAL TRIAL (R01 CLINICAL TRIAL REQUIRED) 03/14/24
ZAI1 VSR-D(M1) NIAID NEW INNOVATORS AWARDS (DP2 CLINICAL TRIAL NOT ALLOWED) 03/11/24
ZAI1 MR-I(M1) SEX DIFFERENCES IN RADIATION RESEARCH: MODELS, UNDERLYING PATHWAYS, BIOMARKERS OF INJURY, AND MEDICAL COUNTERMEASURE RESPONSES (U01 CLINICAL TRIAL NOT ALLOWED) 03/11/24
ZAI1 BJM-A(M1) NIAID RESOURCE RELATED RESEARCH PROJECTS (R24 CLINICAL TRIAL NOT ALLOWED) 03/11/24
ZAI1 LP-I(M1) INVESTIGATOR INITIATED EXTENDED CLINICAL TRIAL (R01 CLINICAL TRIAL REQUIRED) 03/08/24
ZAI1 PT-I(M2) NIAID SBIR PHASE II CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U44 CLINICAL TRIAL REQUIRED) 03/07/24
ZAI1 SB-X(M1) DEVELOPMENT OF SOFTWARE FOR DATA SCIENCE IN INFECTIOUS AND IMMUNE-MEDIATED DISEASES RESEARCH (U01 CLINICAL TRIAL NOT ALLOWED) 03/06/24
ZAI1 AWA-M(M2) NIAID SBIR PHASE II CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U44 CLINICAL TRIAL REQUIRED), CLINICAL TRIAL PLANNING GRANT (R34 CLINICAL TRIAL NOT ALLOWED), CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U01 CLINICAL TRIAL 03/06/24
ZAI1 SAS-M(M2) NIAID CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U01 CLINICAL TRIAL REQUIRED); INVESTIGATOR INITIATED EXTENDED CLINICAL TRIAL (R01 CLINICAL TRIAL REQUIRED) 03/06/24
ZAI1 SA-A(C1) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I: DEVELOPMENT OF LONG-ACTING TREATMENTS FOR HCV CURE (TOPIC 125) 03/01/24
ZAI1 AWA-M(M1) NIAID CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U01 CLINICAL TRIAL REQUIRED); NIAID SBIR PHASE II CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U44 CLINICAL TRIAL REQUIRED); CLINICAL TRIAL PLANNING GRANTS (R34 CLINICAL TRI 02/29/24
ZAI1 DF-M(M1) ANIMAL MODELS FOR HEPATITIS B AND C (R01 CLINICAL TRIAL NOT ALLOWED) 02/29/24
ZAI1 SAS-M(M1) NIAID SBIR PHASE II CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U44 CLINICAL TRIAL REQUIRED); NIAID CLINICAL TRIAL PLANNING GRANTS (R34 CLINICAL TRIAL NOT ALLOWED); NIAID CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT 02/29/24
ZAI1 MR-I(M3) PAR-23-065, NIAID RESOURCE RELATED RESEARCH PROJECTS (R24 CLINICAL TRIAL NOT ALLOWED) 02/29/24
ZAI1 HSC-X(M1) IMMUNE MECHANISMS AT THE MATERNAL-FETAL INTERFACE (R01 CLINICAL TRIAL NOT ALLOWED) 02/28/24
ZAI1 NKD-M(C2) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I: SOFTWARE OR WEB SERVICES TO RE-REPRESENT EXISTING SCIENTIFIC DATA AND KNOWLEDGE INTO A KNOWLEDGE GRAPH FORMAT (TOPIC 136) 02/27/24
ZAI1 BJM-A(C1) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I: DEVELOPMENT OF NOVEL IN-VITRO AND IN-VIVO MODELS TO SUPPORT NEUROHIV RESEARCH (TOPIC 002) 02/27/24
ZAI1 PT-I(M1) NIAID CLINICAL TRIAL IMPLEMENTATION COOPERATIVE AGREEMENT (U01 CLINICAL TRIAL REQUIRED) 02/27/24
ZAI1 PT-I(C1) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I AND PHASE II: REAGENTS FOR IMMUNOLOGIC ANALYSIS OF NON-MAMMALIAN AND UNDERREPRESENTED MAMMALIAN MODELS (TOPIC 129) 02/26/24
ZAI1 SPJ-A(C2) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I: POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYS (TOPIC 001) 02/26/24
ZAI1 JTS-I(C1) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I AND PHASE II: ADJUVANT DISCOVERY AND DOWN-SELECTION FOR VACCINES AGAINST INFECTIOUS AND IMMUNE-MEDIATED DISEASES (TOPIC 130) 02/23/24
ZAI1 PP-A(C1) HHS-NIH-SBIR PHS 2024-1 PHASE I/II: DEVELOPMENT OF NEXT-GEN DEVICES AND MATERIALS-BASED PLATFORMS FOR THE ADMIN OF HIV-1 BNABS (TOPIC 124); PHS 2020-1 PHASE II: PARTICLE-BASED CO-DELIVERY OF HIV IMMUNOGENS AS NEXT-GEN VACCINES (TOPIC 77) 02/22/24
ZAI1 LK-A(C1) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I: RAPID DIAGNOSTIC ASSAYS FOR SELF-MONITORING OF ACUTE OR REBOUND HIV-1 INFECTION (TOPIC 126) 02/22/24
ZAI1 SPJ-A(C1) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I: SOFTWARE OR WEB SERVICES TO AUTOMATE METADATA ENRICHMENT AND STANDARDIZATION FOR DATA ON INFECTIOUS AND IMMUNE – MEDIATED DISEASES (TOPIC 135) 02/21/24
ZAI1 SJ-M(C2) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I: DEVELOPMENT OF BACTERIOPHAGE FOR TREATMENT OF MYCOBACTERIAL INFECTIONS (TOPIC 131) 02/21/24
ZAI1 MN-M(C1) SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II PROGRAM CONTRACT SOLICITATION (PHS 2022-1) TOPIC 108 - DEVELOPMENT OF RAPID POC DIAGNOSTICS FOR TREPONEMA PALLIDUM (N01) 02/16/24
ZAI1 SAG-A(C1) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I/II: MULTIPLEXED PATIENT ADMINISTERED DIAGNOSTICS FOR HEPATITIS B, HEPATITIS C, AND HIV (TOPIC 127) 02/15/24
ZAI1 MN-M(C2) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I: NOVEL DIAGNOSTIC BIOMARKER DISCOVERY AND VALIDATION FOR MALARIA AND SELECT NEGLECTED TROPICAL DISEASES (NTDS) (TOPIC 132) 02/15/24
ZAI1 SJ-M(C1) SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II PROGRAM CONTRACT SOLICITATION (PHS 2022-1) TOPIC 112 - DIGITAL TOOLS AGAINST MISINFORMATION ABOUT INFECTIOUS DISEASE TREATMENTS AND VACCINES (N01) 02/14/24
ZAI1 KAR-M(C2) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I: ALTERNATIVES TO BENZATHINE PENICILLIN FOR TREATMENT OF SYPHILIS (TOPIC 134) 02/12/24
ZAI1 MMO-I(C1) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I: ADJUVANT DEVELOPMENT FOR VACCINES FOR INFECTIOUS AND IMMUNE-MEDIATED DISEASES (TOPIC 128) 02/08/24
ZAI1 KJK-I(C1) NIAID SPF MACAQUE BREEDING COLONIES 02/07/24
ZAI1 NKD-M(C1) SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II PROGRAM CONTRACT SOLICITATION (PHS 2022-1) TOPIC 109 - DEVELOPMENT OF MONOCLONAL ANTIBODY-MEDIATED INTERVENTIONS TO COMBAT MALARIA (N01) 02/06/24
ZAI1 KAR-M(C1) HHS-NIH-CDC-SBIR PHS 2024-1 PHASE I: DEVELOPMENT OF A SEROLOGICAL TEST FOR HERPES SIMPLEX TYPES 1 AND 2 INFECTIONS (TOPIC 133) 02/06/24
ZAI1 RK-M(M1) BIOINFORMATICS RESOURCE CENTERS (BRCS) FOR INFECTIOUS DISEASES (U24 CLINICAL TRIAL NOT ALLOWED) 01/31/24
ZAI1 RCU-A(J1) PA20-186, MIDCAREER INVESTIGATOR AWARD IN PATIENT-ORIENTED RESEARCH (PARENT K24 INDEPENDENT CLINICAL TRIAL NOT ALLOWED) 01/24/24
ZAI1 LP-I(C1) INNOVATIONS IN FUNCTIONAL B CELL EPITOPE DISCOVERY (N01) 01/18/24
ZAI1 SA-A(J2) NIAID INVESTIGATOR INITIATED PROGRAM PROJECT APPLICATIONS (P01 CLINICAL TRIAL NOT ALLOWED) 01/09/24